{"paper_id":"9ad27142-b085-4fc3-b220-2cec86cec10a","body_text":"Year 2025 / Volume 117 / Number 12\nLetter\nLetter\nBenign multicystic peritoneal mesothelioma: use of hyperthermic intraperitoneal chemotherapy (HIPEC)\n799-800DOI: 10.17235/reed.2025.11416/2025\nSilvia Sánchez Infantes, César Lévano-Linares, Tamara Diaz Vico, María Teresa Pérez Domene, Ana Torres Alemán, Belén Manso Abajo, Manuel Durán Poveda,\nAbstract\nBenign Multicystic Peritoneal Mesothelioma (BMPM) is a rare mesothelial neoplasm, first described in 1979, with an estimated incidence of 1–2 cases per million. It primarily affects women of reproductive age and has been associated with chronic inflammatory processes such as endometriosis or previous surgeries. Due to its clinical and radiological similarity to ovarian neoplasms, it is essential to include gynecological pathology in the differential diagnosis.\nNew comment\nComments\nNo comments for this article\nReferences\n1. Mennemeyer R, Smith M. Multicystic, peritoneal mesothelioma: a report with electron microscopy of a case mimicking intra-abdominal cystic hygroma (lymphangioma). Cancer. 1979; 44(2):692-8. doi: 10.1002/1097-0142(197908)44:2692::aid-cncr2820440242>3.0.co;2-6.\n2. Rapisarda A.M.C., Cianci A., Caruso S., et al. Benign multicystic mesothelioma and peritoneal inclusion cysts: are they the same clinical and histopathological entities? A systematic review to find an evidence-based management. Arch. Gynecol. Obstet. 2018; 297 (6):1353-1375. DOI: 10.1007/s00404-018-4728-2.\n3. Kepenekian V, Peron J, Goéré D, et al. Multicystic peritoneal mesotelioma treated wirh cytoreductive surgery followed or not by hyperthermic intraperitoneal chemotherapy: results from a large multicentric cohort. Int J Hyperthermia 2021; 38 (1): 805-814.\n4. Shikanai S, Mariya T, Iwasaki M, et al. Benign Multicystic Peritoneal Mesothelioma Complicating Fertility Preservation. Gynecol Minim Invasive Ther. 2022; 11(2): 137-138. DOI: 10.4103/GMIT.GMIT_43_21.\n5. Zahid A, Clarke L, Carr N, et al. Outcomes of multicystic peritoneal mesothelioma treatment with cytoreductive surgery and hypethermic intraperitoneal chemotherapy. BJS open 2020 (0). DOI: 10.1093/bjopen/zraa001.\nRelated articles\nLetter\nDOI: 10.17235/reed.2020.6755/2019\nLetter to the Editor\nDOI: 10.17235/reed.2017.5179/2017\nCitation tools\nSánchez Infantes S, Lévano-Linares C, Diaz Vico T, Pérez Domene M, Torres Alemán A, Manso Abajo B, et all. Benign multicystic peritoneal mesothelioma: use of hyperthermic intraperitoneal chemotherapy (HIPEC). 11416/2025\nDownload the citation for this article by clicking on one of the following citation managers:\nMetrics\nPublication history\nReceived: 15/06/2025\nAccepted: 19/06/2025\nOnline First: 04/07/2025\nPublished: 12/12/2025\nArticle Online First time: 19 days\nArticle editing time: 180 days\nShare\nThis article hasn't been rated yet.\nReader rating:\nValora este artículo:\nSubmit a manuscript\nJournal info\nArticles\nSubmit a manuscript\nJournal info\nArticles\nSubmit a manuscript\nThe Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva\nCookie policy\nPrivacy Policy\nLegal Notice\n© Copyright 2026 y Creative Commons. The Spanish Journal of Gastroenterology","source_license":"public-domain-us","license_restricted":false}